Related Experiment Video
Updated: Oct 11, 2025

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
Published on: March 29, 2024
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
Husam M Salah1, Ambarish Pandey2, Anzhela Soloveva3
1Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Insights
Heart failure with preserved ejection fraction (HFpEF) and nonalcoholic fatty liver disease (NAFLD) are linked. This review proposes distinct NAFLD-related HFpEF phenotypes and discusses diagnosis and treatment for this understudied association.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- Established bidirectional link between reduced ejection fraction heart failure and liver disease.
- Limited exploration of the association between heart failure with preserved ejection fraction (HFpEF) and liver diseases like nonalcoholic fatty liver disease (NAFLD).
Purpose of the Study:
- To review the relationship between HFpEF and NAFLD.
- To propose novel NAFLD-related HFpEF phenotypes.
- To discuss diagnostic challenges and treatment strategies for concurrent NAFLD and HFpEF.
Main Methods:
- In-depth literature review.
- Phenotypic classification of NAFLD-related HFpEF.
- Discussion of diagnostic and therapeutic considerations.
Main Results:
- Identification of three proposed NAFLD-related HFpEF phenotypes: obstructive HFpEF, metabolic HFpEF, and advanced liver fibrosis HFpEF.
- Highlighting diagnostic complexities in patients with co-existing NAFLD and HFpEF.
- Outlining potential treatment avenues for these specific phenotypes.
Conclusions:
- NAFLD-related HFpEF represents a significant, under-explored clinical entity.
- Recognition of distinct NAFLD-related HFpEF phenotypes is crucial for targeted management.
- Further research is warranted to elucidate the pathophysiology and optimize treatment of NAFLD-related HFpEF.
Abstract:
Although there is an established bidirectional relationship between heart failure with reduced ejection fraction and liver disease, the association between heart failure with preserved ejection fraction (HFpEF) and liver diseases, such as nonalcoholic fatty liver disease (NAFLD), has not been well explored. In this paper, the authors provide an in-depth review of the relationship between HFpEF and NAFLD and propose 3 NAFLD-related HFpEF phenotypes (obstructive HFpEF, metabolic HFpEF, and advanced liver fibrosis HFpEF). The authors also discuss diagnostic challenges related to the concurrent presence of NAFLD and HFpEF and offer several treatment options for NAFLD-related HFpEF phenotypes. The authors propose that NAFLD-related HFpEF should be recognized as a distinct HFpEF phenotype.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure I: Introduction
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure III: Clinical Manifestations
Heart Failure VII: Nursing Interventions

